Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05288517 · ClinicalTrials.gov registry record · NA
A Randomized Control Trial of a Digital Health Tool
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 20,131
- Enrollment target
NCT05288517 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 20,131 participants.
The verdict
NCT05288517, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 20,131 participants
- Enrollment target
Study Summary
This randomized trial evaluated whether sending population-based invitation messages through the electronic health record to visit Lock to Live (L2L), a web-based decision aid that incorporates patients' values into recommendations for safe storage of firearms and medications, impacted readiness to change firearm and medication storage behaviors.
Interventions
- BEHAVIORAL Lock to Live
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,131 participants |
| Start Date | 2021-04-19 |
| Est. Completion | 2022-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05288517
The ClinicalTrials.gov registry entry for NCT05288517 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20,131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lock to Live is the first listed.
NCT05288517 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05288517 about?
NCT05288517 is a clinical study titled "A Randomized Control Trial of a Digital Health Tool". This randomized trial evaluated whether sending population-based invitation messages through the electronic health record to visit Lock to Live (L2L), a web-based decision aid that incorporates patients' values into recommendations for safe storage of firearms and medications, impacted readiness to ...
What is the current status of trial NCT05288517?
This trial is currently completed. It is a NA study. The enrollment target is 20,131 participants. The study started on 2021-04-19. Estimated completion is 2022-03-01.
What interventions are being tested in trial NCT05288517?
The interventions under investigation include: Lock to Live (BEHAVIORAL).
Who is sponsoring clinical trial NCT05288517?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.